These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 35646059)
1. Upregulation of Ferroptosis-Related Fanconi Anemia Group D2 is a Poor Prognostic Factor and an Indicator of Tumor Immune Cell Infiltration in Lung Adenocarcinoma. Zhang J; Wang D; Chen X; Ji L; Yu M; Guo M; Zhang D; Chen W; Xu F Front Genet; 2022; 13():825685. PubMed ID: 35646059 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of the autophagy-dependent ferroptosis-related gene FANCD2 in lung adenocarcinoma. Miao H; Ren Q; Li H; Zeng M; Chen D; Xu C; Chen Y; Wen Z BMC Cancer; 2022 Mar; 22(1):225. PubMed ID: 35236309 [TBL] [Abstract][Full Text] [Related]
3. Ferroptosis regulator FANCD2 is associated with immune infiltration and predicts worse prognosis in lung adenocarcinoma. Ye C; Lu Y; Yuan Z; Mi M; Qi L; Yuan Y; Weng S Front Genet; 2022; 13():922914. PubMed ID: 36267413 [TBL] [Abstract][Full Text] [Related]
4. FANCD2 as a novel prognostic biomarker correlated with immune and drug therapy in Hepatitis B-related hepatocellular carcinoma. Tang X; Luo B; Huang S; Jiang J; Chen Y; Ren W; Shi X; Zhang W; Shi L; Zhong X; Lü M Eur J Med Res; 2023 Oct; 28(1):419. PubMed ID: 37821996 [TBL] [Abstract][Full Text] [Related]
5. STARD12/14 are diagnostic and prognostic biomarkers of lung adenocarcinoma associated with epigenetic regulation, immune infiltration and ferroptosis. Zhang WD; Hu DM; Shi ZE; Wang QX; Zhang MY; Liu JY; Ji XL; Qu YQ Int J Med Sci; 2023; 20(11):1427-1447. PubMed ID: 37790851 [No Abstract] [Full Text] [Related]
6. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma. Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340 [TBL] [Abstract][Full Text] [Related]
7. System analysis of Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116 [TBL] [Abstract][Full Text] [Related]
8. Ferroptosis and WDFY4 as novel targets for immunotherapy of lung adenocarcinoma. Huang L; Zhong L; Cheng R; Chang L; Qin M; Liang H; Liao Z Aging (Albany NY); 2023 Sep; 15(18):9676-9694. PubMed ID: 37728413 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of Li B; Li X; Yang Q; Jiang Y; Zhang Q; Zhang J; Cui W; Xu F Aging (Albany NY); 2024 Feb; 16(3):2953-2977. PubMed ID: 38329443 [TBL] [Abstract][Full Text] [Related]
10. Identification of critical ferroptosis regulators in lung adenocarcinoma that RRM2 facilitates tumor immune infiltration by inhibiting ferroptotic death. Tang B; Xu W; Wang Y; Zhu J; Wang H; Tu J; Weng Q; Kong C; Yang Y; Qiu R; Zhao Z; Xu M; Ji J Clin Immunol; 2021 Nov; 232():108872. PubMed ID: 34648954 [TBL] [Abstract][Full Text] [Related]
11. Crosstalk of ferroptosis regulators and tumor immunity in pancreatic adenocarcinoma: novel perspective to mRNA vaccines and personalized immunotherapy. Shi Y; Wang Y; Dong H; Niu K; Zhang W; Feng K; Yang R; Zhang Y Apoptosis; 2023 Oct; 28(9-10):1423-1435. PubMed ID: 37369808 [TBL] [Abstract][Full Text] [Related]
12. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma. Ma C; Kang W; Yu L; Yang Z; Ding T Front Oncol; 2020; 10():590006. PubMed ID: 33363020 [TBL] [Abstract][Full Text] [Related]
13. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Li N; Li Y; Zheng P; Zhan X Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015 [TBL] [Abstract][Full Text] [Related]
14. KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker. Shen X; Mo X; Tan W; Mo X; Li L; Yu F; He J; Deng Z; Xing S; Chen Z; Yang J Pathol Oncol Res; 2022; 28():1610754. PubMed ID: 36419650 [No Abstract] [Full Text] [Related]
15. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level. Wang W; Ren S; Wang Z; Zhang C; Huang J Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070 [TBL] [Abstract][Full Text] [Related]
16. Integrative analyses of prognosis, tumor immunity, and ceRNA network of the ferroptosis-associated gene FANCD2 in hepatocellular carcinoma. Yang Z; Song Y; Li Y; Mao Y; Du G; Tan B; Zhang H Front Genet; 2022; 13():955225. PubMed ID: 36246623 [TBL] [Abstract][Full Text] [Related]
17. Zc3h12d, a Novel of Hypomethylated and Immune-Related for Prognostic Marker of Lung Adenocarcinoma. Yang B; Ji LL; Xu HL; Li XP; Zhou HG; Xiao T; Li XH; Gao ZY; Li JZ; Zhang WD; Wang GS; Li MJ J Inflamm Res; 2021; 14():2389-2401. PubMed ID: 34163207 [TBL] [Abstract][Full Text] [Related]
18. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures. Zhang X; Wang Y; A G; Qu C; Chen J Front Immunol; 2021; 12():721030. PubMed ID: 34531868 [TBL] [Abstract][Full Text] [Related]
19. Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128 [TBL] [Abstract][Full Text] [Related]
20. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Zuo S; Wei M; Wang S; Dong J; Wei J Front Immunol; 2020; 11():1218. PubMed ID: 32714316 [No Abstract] [Full Text] [Related] [Next] [New Search]